Wedmont Private Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Buy
1,413
+191
+16% +$57.6K 0.01% 613
2026
Q1
$400K Buy
1,222
+109
+10% +$37.1K 0.01% 572
2025
Q4
$470K Buy
1,113
+58
+5% +$25.7K 0.02% 498
2025
Q3
$485K Sell
1,055
-706
-40% -$287K 0.02% 470
2025
Q2
$565K Buy
1,761
+169
+11% +$46.8K 0.02% 396
2025
Q1
$379K Buy
1,592
+107
+7% +$27.5K 0.02% 453
2024
Q4
$353K Buy
1,485
+8
+0.5% +$2.1K 0.02% 487
2024
Q3
$394K Buy
1,477
+243
+20% +$63.3K 0.02% 435
2024
Q2
$321K Buy
+1,234
New +$195K 0.02% 477
2023
Q1
Sell
-927
Closed -$209K 466
2022
Q4
$209K Buy
+927
New +$198K 0.03% 418

Other funds holding ALNY